Kidney-gut crosstalk in renal disease
- PMID: 33216316
- DOI: 10.1007/s11845-020-02437-7
Kidney-gut crosstalk in renal disease
Abstract
Introduction: The colon has an important role in managing nitrogenous waste products, electrolytes, and mineral balance during kidney diseases. However, colonic microbiota produces uremic toxins, such as indoxyl sulfate and p-cresyl sulfate, in chronic kidney disease (CKD) patients, which due to their proinflammatory properties contribute to CKD progression. Conversely, in acute renal injury patients, intestinal microbiota could reduce inflammation by secreting short-chain fatty acids and inducing a renal protective immune response. However, since the intestines are the most frequently affected organ in advanced sepsis, colonic microbiota can also represent a negative factor for kidney health in this scenario.
Conclusion: In the present review, the main characteristics of kidney-gut crosstalk are described.
Keywords: Crosstalk; Gut; Kidney.
© 2020. Royal Academy of Medicine in Ireland.
References
-
- Muso CG (2020) Biosemiotic medicine: from an effect-based medicine to a process-based medicine. Arch Argent Pediatr 118(5):e449–e453
-
- Poesen R, Meijers B, Evenepoel P (2013) The colon: an overlooked site for therapeutics in dialysis patients. Semin Dial 26(3):323–332 - DOI
-
- Ranganathan N, Ranganathan P, Friedman EA et al (2010) Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 27(9):634–647. https://doi.org/10.1007/s12325-010-0059-9 - DOI - PubMed
-
- Musso CG (2004) Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). Int Urol Nephrol 36(3):469–472 - DOI
-
- Vaziri ND (2016) Effect of synbiotic therapy on gut-derived uremic toxins and the intestinal microbiome in patients with CKD. Clin J Am Soc Nephrol 11(2):199–201 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical